Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

One-fifth of stem cell transplantation patients develop PTSD

Key clinical point: Approximately one-fifth of patients with hematologic malignancies undergoing hematopoietic stem cell transplantation may develop posttraumatic stress disorder.

Major finding: Six months after transplantation, 18.9% of patients had symptoms of posttraumatic stress disorder.

Study details: An observational study involving 250 adults with hematologic malignancies who underwent hematopoietic stem cell transplantation.

Disclosures: The study was funded by the Lymphoma and Leukemia Society. The investigators disclosed additional relationships with Vector Oncology, Pfizer, AstraZeneca, and Gaido Health/BCG Digital Ventures.

Citation:

Griffith et al. ASCO 2020. Abstract # 7505.